2013/11/10 12:00
Conditions: Psoriasis; Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Gliclazide; Drug: Sitagliptin matched placebo; Drug: Gliclazide matched placebo capsule
Sponsor: University College Dublin
Not yet recruiting - verified November 2013
2013/10/10 12:00
Conditions: Drug Mechanism; Drug Usage
Intervention:
Sponsors: Bezmialem Vakif University; Bezmialem Vakif University
Completed - verified October 2013
2013/3/13 12:00
Condition: Type 2 Diabetes
Interventions: Drug: Gliclazide 80mg OD; Drug: Sitagliptin 100mg OD
Sponsors: NIHR Exeter Clinical Research Facility; NIHR Exeter Clinical Research Facility; University of Exeter
Not yet recruiting - verified March 2013
2013/1/14 12:00
Condition: Type 2 Diabetes
Interventions: Procedure: Duodenal jejunal bypass plus sleeve gastrectomy; Drug: Best medical treatment (Metformin ; gliclazide)
Sponsors: University of Sao Paulo; University of Sao Paulo
Active, not recruiting - verified January 2013
2012/12/24 12:00
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin; Drug: Gliclazide; Drug: Metformin; Drug: Placebo to Gliclazide; Drug: Placebo to Vildagliptin
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified December 2012
2012/10/16 12:00
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin; Drug: Sitagliptin; Drug: Acarbose; Drug: Repaglinide; Drug: Glimepiride; Drug: Gliclazide
Sponsors: Merck; Merck
Not yet recruiting - verified October 2012
2012/9/28 12:00
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK-3102; Drug: Matching placebo to MK-3102; Drug: Basal medication
Sponsors: Merck; Merck
Not yet recruiting - verified October 2012
2011/4/18 12:00
Condition: Type 2 Diabetes
Intervention: Drug: Vildagliptin
Sponsor: University of Zurich
Recruiting - verified August 2011
2011/1/4 12:00
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Janumet, Lantus; Drug: metformin, gliclazide, protaphane
Sponsor: Chinese University of Hong Kong
Not yet recruiting - verified December 2010
2010/11/15 12:00
Condition: Type 2 Diabetes Mellitus
Interventions: Device: ASP1941; Drug: Placebo; Drug: Sulfonylurea
Sponsor: Astellas Pharma Inc
Active, not recruiting - verified March 2011
2010/9/3 12:00
Conditions: Hyperglycemia; Diabetes
Intervention:
Sponsor: Taipei Medical University WanFang Hospital
Recruiting - verified September 2010
2010/9/1 12:00
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: allocation of treatment with metformin or rosiglitazone
Sponsor: GlaxoSmithKline
Completed - verified September 2010
2010/2/24 12:00
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: sitagliptin phosphate; Drug: Comparator: placebo to pioglitazone; Drug: Comparator: placebo to sitagliptin; Drug: Comparator: pioglitazone; Drug: Comparator: glimepiride or gliclazide; Drug: Comparator: metformin; Drug: Comparator: pioglitazone rescue therapy
Sponsor: Merck
Active, not recruiting - verified January 2011
2009/11/26 12:00
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: repaglinide; Drug: gliclazide
Sponsor: Novo Nordisk
Completed - verified January 2011
2009/9/14 12:00
Condition: Diabetes
Intervention:
Sponsors: Chongqing Medical University; Fuling Central Hospital; Three Gorges Central Hospital
Recruiting - verified September 2009
2009/7/28 12:00
Condition: Diabetes Mellitus, Type 2
Intervention:
Sponsors: The George Institute; Servier
Not yet recruiting - verified April 2010
2009/1/26 12:00
Condition: Hyperglycemia
Interventions: Drug: Insulatard (long-acting insulin); Drug: Conventional
Sponsor: Medical University of Vienna
Active, not recruiting - verified January 2009
2008/12/15 12:00
Condition: Type 2 Diabetes
Interventions: Dietary Supplement: GP group; Dietary Supplement: Placebo group
Sponsors: Hanoi Medical University; Karolinska Institutet; Swedish International Development Cooperation Agency (SIDA)
Completed - verified December 2008
2008/10/27 12:00
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Gliclazide MR; Drug: Sitagliptin; Drug: Pioglitazone; Drug: Metformin
Sponsor: University of Dundee
Enrolling by invitation - verified October 2008
2008/8/18 12:00
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: gliclazide
Sponsor: NHS Tayside
Enrolling by invitation - verified August 2008